Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

Liver diseases are fast emerging as global health priorities. Fatty liver is described in the
setting of non-alcoholic fatty liver disease (NAFLD) as well as alcoholic liver disease (ALD) …

As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …

Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third
cause of cancer-related death in the Western Countries. The well-established causes of …

Hepatocellular carcinoma (HCC) is a common malignancy and one of the leading causes of
cancer-related death. The biological process of HCC is complex, with multiple factors …

Simple Summary Hepatocellular carcinoma (HCC) is an aggressive human cancer and is
caused as consequences of chronic liver diseases. Although HCC is more common in …

Objective As the current therapeutic strategies for human hepatocellular carcinoma (HCC)
have been proven to have limited effectiveness, immunotherapy becomes a compelling way …

Non-alcoholic fatty liver disease (NAFLD) is a complex disease, affecting not just the liver,
but also all other organs in the body. Despite an increasing amount of people worldwide …

The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the
resistance of HCC cells to traditional treatments and tumor recurrence after curative …

Background There is a wide variation across studies in the reported prevalence of
nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). A …